SCHEMBL1824344

SCHEMBL1824344

COC(=O)C(OC)c1cccc(OS(=O)(=O)c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 1/20 0.45
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KMT2A Q03164 2/20 0.42
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.41
GPR17 Q13304 1/20 0.41
ADAMTS4 O75173 1/20 0.40
FAAH O00519 1/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ENPP3 O14638 1/20 0.39
ENPP1 P22413 1/20 0.39
ENPP2 Q13822 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827374 0.90 GPR17 (0.47) ALDH1A1KMT2AHTTLMNAMAPT
SCHEMBL1826863 0.89 ADRB3 (0.43) ADRB3ALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL1823861 0.88 ALDH1A1 (0.44) ADRB3ALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL1824603 0.88 ADRB3 (0.42) ADRB3ALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL1823272 0.87 FAAH (0.44) ADRB3ALDH1A1SMN1; SMN2KMT2AFAAH
SCHEMBL1826073 0.86 SMN1; SMN2 (0.44) ADRB3ALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL2839041 0.86 PTGS1 (0.56) ADRB3ALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL1826116 0.85 TDP1 (0.49) ALDH1A1SMN1; SMN2KMT2AHTTLMNA
SCHEMBL1824283 0.85 L3MBTL1 (0.40) ALDH1A1KMT2AL3MBTL1FAAHKDM4E
SCHEMBL1826099 0.85 KMT2A (0.49) ADRB3ALDH1A1SMN1; SMN2KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ADRB3 1280/4885ALDH1A1 1099/4885SMN1; SMN2 2274/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ADRB3 1134/4885ALDH1A1 1440/4885SMN1; SMN2 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.